A method for predicting the risk of developing bladder cancer

摘要

bladder cancer risk prediction process (RMP), characterized in that from lymphocytes of peripheral venous blood isolated DNA analyze the polymorphic locus Ile462Val gene CYP1A1 by NDP followed by restriction digestion of amplified fragments, detection of the genotype Ile / Val or Val / Val predict high the risk of developing bladder cancer, and upon detection of genotype Ile / Ile predict resistance to the development of the disease.